Since October 1983, ÐÇ¿ÕÓéÀÖ¹ÙÍø's Division of Tuberculosis Control,
Center
for Prevention Services, has supplied the experimental drug,
ansamycin
LM427, under a "compassionate" investigational new drug permit to
physicians treating patients with serious mycobacterial disease
unresponsive to conventional therapy. Beginning Monday, February
18,
1985, physicians requesting the drug for new patients should
contact
the ÐÇ¿ÕÓéÀÖ¹ÙÍø Drug Service at (404) 329-3670 during normal working hours.
Ansamycin LM427 is not released at night or during weekends. The
Division of Tuberculosis Control ((404) 329-2530) will continue to
provide medical consultation on the treatment of mycobacterial
diseases.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to [email protected].
